Bicycle Therapeutics is reducing…
Bicycle Therapeutics is reducing its headcount by around 25% to [...]
Longevity company Altos Labs has…
Longevity company Altos Labs has secured a new clinical leader [...]
An impressive array of Big Pharma…
An impressive array of Big Pharma backers lined up to [...]
Eli Lilly is pivoting its pain…
Eli Lilly is pivoting its pain pipeline, punting a midstage [...]
Minghui has secured $131 million…
Minghui has secured $131 million for what the company describes [...]
Gilead has returned the rights to…
Gilead has returned the rights to a cancer candidate it [...]
Keros has shaken up its leadership…
Keros has shaken up its leadership structure as the biotech [...]
As other pharmas drop next-gen…
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental [...]
The Trump administration has…
The Trump administration has broken the law by withholding funds [...]
Alltrna, the preclinical Flagship…
Alltrna, the preclinical Flagship Pioneering-backed biotech trying to turn transfer [...]